Cognito Therapeutics is a pioneer in non-invasive neuromodulation to treat neurodegenerative diseases and improve human cognitive performance. The company has completed multiple clinical studies demonstrating its investigational therapeutic has the potential to safely slow or stop cognitive decline and loss of brain volume in Alzheimer’s disease. 


https://www.cognitotx.com/

Cognito Therapeutics Ltd announced it raised $10.2 Million in an initial filing from an offering of $60 Million

Company Information

Related People

Funding Insights

Cognito Therapeutics Ltd announced it raised $10.2 Million in an initial filing from an offering of $60 Million

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Funding Insights

Company Information